Research Paper Volume 12, Issue 9 pp 8640—8651
Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models
Figure 2. Exenatide treatment improves cardiomyocytes function under hyperglycemia stress. (A–D) Signal of cardiomyocyte contractile parameters measured in response to Exenatide treatment. (E, F) Myosin expression determined through immunofluorescence. *P<0.05.